Skip to main content

Ocugen, Inc. (OCGN)

NASDAQ: OCGN · IEX Real-Time Price · USD
8.40
+0.08 (0.96%)
After-hours:Oct 22, 2021 7:59 PM EDT
8.32
-0.14 (-1.65%)
At close: Oct 22, 4:00 PM
Market Cap1.65B
Revenue (ttm)-380
Net Income (ttm)-47.29M
Shares Out195.57M
EPS (ttm)-0.27
PE Ration/a
Forward PE16.03
Dividendn/a
Ex-Dividend Daten/a
Volume21,468,929
Open8.03
Previous Close8.46
Day's Range7.75 - 8.39
52-Week Range0.25 - 18.77
Beta4.30
AnalystsBuy
Price Target8.88 (+6.7%)
Est. Earnings DateNov 5, 2021

About OCGN

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410, gene therapy candidate for the treatment of dry age-related macular degeneration (AMD); and OCU200, a novel fusion protein that is in preclinical development st...

IndustryBiotechnology
CEOShankar Musunuri
Employees15
Stock ExchangeNASDAQ
Ticker SymbolOCGN
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 5 analysts, the average rating for Ocugen stock is "Buy." The 12-month stock price forecast is 8.88, which is an increase of 6.73% from the latest price.

Price Target
$8.88
(6.73% upside)
Analyst Consensus: Buy

News

3 Under-the-Radar COVID Stocks

Some COVID-19 stocks are pretty famous. But other lesser-known names are flying high, too.

Other symbols:CYRXNARI
3 days ago - The Motley Fool

3 Biotech Stocks That Are Ridiculously Overpriced

They've risen too far, too quickly.

Other symbols:MRNASAVA
3 days ago - The Motley Fool

Ocugen Surged on Its Covid Vaccine Emergency Approval in India

OCGN stock has suffered as a Covid-19 vaccine latecomer, but news that Covaxin won emergency approval in India sent shares soaring. The post Ocugen Surged on Its Covid Vaccine Emergency Approval in Indi...

3 days ago - InvestorPlace

Is Now a Good Time to Buy Ocugen?

There is a lot of uncertainty surrounding this biotech's prospects.

4 days ago - The Motley Fool

Ocugen Inc. to present pre-clinical data for OCU410 at 2nd Annual Dry AMD Therapeutic Development Conference

MALVERN, Pa., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases...

4 days ago - GlobeNewsWire

This Ocugen Stock Rally Makes Little Sense, But Watch Out Going Short

Highly volatile, with a tendency to make unwarranted moves higher, it's best to not go long (or short) OCGN stock. The post This Ocugen Stock Rally Makes Little Sense, But Watch Out Going Short appeared...

4 days ago - InvestorPlace

Why Shares of Dynavax Technologies, Ocugen, and Valneva Are on the Move Today

These COVID-19 vaccine developers are all moving in response to strong late-stage results for Valneva's VLA2001.

Other symbols:DVAX
4 days ago - The Motley Fool

Is Ocugen Stock Heading for a Crash?

The stock soared more than 22% this past week.

6 days ago - The Motley Fool

Ocugen Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., Oct. 16, 2021 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases...

1 week ago - GlobeNewsWire

Why Shares of Moderna, Novavax, and Ocugen Are Falling Today

These COVID-19 vaccine makers are sinking on nothing more than good old-fashioned uncertainty.

Other symbols:MRNANVAX
1 week ago - The Motley Fool

Ocugen Is a Strong Sell, Vaccine Unlikely to Find Commercial Success

Ocugen has historically had a terrible track record. There's little reason to think its current vaccine effort will end any better for OCGN stock.

1 week ago - InvestorPlace

Why Ocugen Stock Is Skyrocketing This Week

Positive developments for COVID-19 vaccine Covaxin appear to have kicked off a short squeeze.

1 week ago - The Motley Fool

OCGN Stock: One Big Reason Why Ocugen Is Climbing Today

Covid-19 vaccine play Ocugen is seeing impressive investor interest today, with OCGN stock seeing double-digit gains at the time of writing. The post OCGN Stock: One Big Reason Why Ocugen Is Climbing To...

1 week ago - InvestorPlace

Ocugen Stock Needs a Catalyst for Growth That Probably Isn't Coming

InvestorPlace's Louis Navellier believes all Ocugen needs is a catalyst. On Oct. 4, OCGN stock got two.

1 week ago - InvestorPlace

Is This Going To Be The Next Big Factor For Ocugen (OCGN) Stock?

Shares of biopharmaceutical company Ocugen Inc. (NASDAQ: OCGN) surged almost 18.5% in Tuesday's regular trading session, extending gains to a second straight day. What Happened: Ocugen's shares extended...

1 week ago - Benzinga

Why Ocugen Stock Is Rallying While Moderna, Novavax, Vaxart Can't Catch Up

Ocugen Inc. (NASDAQ:OCGN) shares were trading higher Tuesday after the Indian government approved Bharat Biotech's COVID-19 vaccine Covaxin, for children between the ages of 2 and 18. Ocugen is partnere...

Other symbols:MRNANVAXVXRT
1 week ago - Benzinga

Hot Penny Stocks for Tuesday: Today's 10 Biggest Movers

Penny stocks are on the move Tuesday and we're taking a look at what's hot among traders of the volatile investments today. The post Hot Penny Stocks for Tuesday: Today's 10 Biggest Movers appeared firs...

1 week ago - InvestorPlace

OCGN Stock: One Big Reason Ocugen Is Powering Higher Today

OCGN stock is making its investors quite happy this morning and prompting many more to pile in. The company is receiving crucial approval.

1 week ago - InvestorPlace

Why Ocugen Stock Is on Fire Today

A positive regulatory development in India is sending the biotech's shares higher today.

1 week ago - The Motley Fool

Ocugen Will Have Value If Its Covid Vaccine Can Get Approved

OCGN stock could be at a full value today given its revenue prospects but could still rise if its Covaxin vaccine gains approval outside India. The post Ocugen Will Have Value If Its Covid Vaccine Can G...

1 week ago - InvestorPlace

Don't Buy Too Much Into the WHO Hype Surrounding Ocugen Stock

Admittedly, one last boost may still be on the table, if meme traders use subsequent WHO news as reason to send OCGN stock back to double-digit prices. But with its high chances of ultimately collapsing...

1 week ago - InvestorPlace

Why Did Ocugen Stock Skyrocket On Monday?

Shares of biopharmaceutical company Ocugen Inc. (NASDAQ: OCGN) surged almost 8.8% in Monday's regular trading session and also gained 11.4% in the after-hours session. What Happened: Ocugen's shares ral...

1 week ago - Benzinga

5 Top Stock Trades for Tuesday: SOFI, LUV, TSLA, T, OCGN

SoFi, Southwest Airlines, Tesla, AT&T and Ocugen were our top stock trades for Tuesday. Now, let's look at how the charts are setting up.

Other symbols:LUVSOFITSLA
1 week ago - InvestorPlace

OCUGEN INVESTIGATION CONTINUED By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate ...

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues to investigate O...

2 weeks ago - Business Wire

WHO To Finalize Nod To Ocugen-Partnered Covaxin Next Week: Sources

The World Health Organization said a decision on the Emergency Use Listing (EUL) of India's COVID-19 vaccine, Covaxin, will be finalized next week. Ocugen Inc (NASDAQ: OCGN) is the U.S. partner for the ...

2 weeks ago - Benzinga